Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
anticonvulsants
anticonvulsants, loading dose
anticonvulsants, parenteral administration
anticonvulsants, rate of administration
anticonvulsants, selection of
anticonvulsants, untoward effects of
children
cluster headache
DHE
dilantin
drug interactions
efficacy
emergencies, neurologic
ergotamine
headache
headache, intractable
headache, severe
headache, treatment of
hypotension, systemic
intravenous
lamotrigine
migraine
migraine, intractable
myoclonus, epilepsy
neuroleptic
neurotoxin
nonsteroidal anti-inflammatory drug
old age, neurology of
oxygen therapy
petit mal status
review article
seizure
seizure, children
seizure, elderly
seizure, intractable
seizure, intractable, treatment of
seizure, treatment of
sodium valproate
sodium valproate, intravenous
status epilepticus
status epilepticus, myoclonic
status epilepticus, nonconvulsive
treatment of neurologic disorder
triptans
valium
Showing articles 550 to 600 of 1768 << Previous Next >>

Clinicopathologic Conference, Paraneoplastic Stiff Person Syndrome with Limbic Encephalitis with Anti-Amphiphysin Antibodies with Metastatic Carcinoma of Breast
NEJM 367:851-861, Case 27-2012, 2012

Solitaire Flow Restoration Device Versus the Merci Retriever in Patients with Acute Ischaemic Stroke (SWIFT): a Randomised, Parallel-Group, Non-Inferiority Trial
Lancet 380:1241-1249,1208, Saver, J.L.,et al, 2012

Trevo Versus Merci Retrievers for Thrombectomy Revascularisation of Large Vessel Occlusions in Acute Ischaemic Stroke (TREVO 2): A Randomised Trial
Lancet 380:1231-1240,1208, Nogueira, R.G.,et al, 2012

Risk Factors for Intracranial Hemorrhage in Acute Ischemic Stroke Patients Treated with Recombinant Tissue Plasminogen Activator
Stroke 43:2904-2909, Whiteley, W.N.,et al, 2012

Time is Brain(stem) in Basilar Artery Occlusion
Stroke 43:3003-3006, Vergouwen, M.D.I.,et al, 2012

Smartphone Teleradiology Application is Succesfully Incorporated Into a Telestroke Network Environment
Stroke 43:3098-3101, Demaerschalk, B.M.,et al, 2012

Fluid-Attenuated Inversion Recovery Vascular Hyperintensity
Arch Neurol 69:1462-1468, Olindo, S.,et al, 2012

Efficacy and Safety of Ketamine in Refractory Status Epilepticus in Children
Neurol 79:2355-2358, Rosati, A.,et al, 2012

Adult-Onset Opsoclonus-Myoclonus Syndrome
Arch Neurol 69:1598-1607, Klaas, J.,et al, 2012

Evidence-based Guideline: Intravenous Immunoglobulin in the Treatment of Neuromascular Disorders
Neurol 78:1009-1015, Patwa,H.S.,et al, 2012

Clinical Reasoning: A Middle-Aged Woman with Progressive Symmetric Weakness and a CSF Pleocytosis
Neurol 78:e88-e92, Marks,D.,et al, 2012

A Randomized Trial of Tenecteplase versus Alteplase for Acute Ischemic Stroke
NEJM 366:1099-1107, Parsons,M.,et al, 2012

Cluster Headache
BMJ 344:e2407, Nesbitt,A.D.,et al, 2012

Autoimmune Epilepsy
Arch Neurol 69:582-593,565, Quek, A.M.L.,et al, 2012

Acute Stroke Imaging: What is Sufficient for Triage to Endovascular Therapies?
AJNR 33:790-792, Lev, M.H., 2012

Factors Influencing In-Hospital Delay in Treatment with Intravenous Thrombolysis
Stroke 43:1578-1583, Mikulik, R.,et al, 2012

Guillain-Barre Syndrome
NEJM 366:2294-2304, Yuki, N. & Hartung, H.P., 2012

Intracranial Dural Arteriovenous Fistulas: Classification, Imaging Findings, and Treatment
AJNR 33:1007-1013, Gandhi, D.,et al, 2012

Infarct Volume is a Pivotal Biomarker After Inter-Arterial Stroke Therapy
Stroke 43:1323-1330, Yoo,A.J.,et al, 2012

Bridging Therapy in Acute Ischemic Stroke
Stroke 43:1302-1308, Mazighi,M.,et al, 2012

Symptomatic Intracranial Hemorrhage after Stroke Thrombolysis: The SEDAN Score
Ann Neurol 71:634-641, Strbian,D.,et al, 2012

Infective Endocarditis at Autopsy
Medicine 91:152-164, Fernandez Guerrero,M.L.,et al, 2012

The Safety of Intravenous Thrombolysis for Ischemic Stroke in Patients with Pre-Existing Cerebral Aneurysms
Stroke 43:412-416, Edwards,N.J.,et al, 2012

Stiff-Man Syndrome and Variants
Arch Neurol 69:230-238, McKeon,A.,et al, 2012

Intramuscular Versus Intravenous Therapy for Prehospital Status Epilepticus
NEJM 366:591-600,659, Silbergleit,R.,et al, 2012

The Argatroban and Tissue-Type Plasminogen Activator Stroke Study
Stroke 43:770-775,623, Barreto,A.D.,et al, 2012

Does Helicopter Emergency Medical Service Transfer Offer Benefit to Patients with Stroke?
Stroke 43:878-880, Olson,M.D. and Rabinstein,A.A., 2012

The Types of Neurological Deficits Might Not Justify Withholding Treatment in Patients with Low Total National Institutes of Health Stroke Scale Scores
Stroke 43:782-786,625, Leira,E.C.,et al, 2012

Selecting Stroke Patients for Intra-Arterial Therapy
Neurol 78:755-761, Balucani,C. and Grotta,J.C., 2012

Safety of Thrombolysis in Patients Over the Age of 80
The Neuroogist 18:99-101, Willey,J.Z.,et al, 2012

Treatment of Multiple System Atrophy Using Intravenous Immunoglobulin
BMC Neurol 12:131, Novak, P.,et al, 2012

Unexplained Hyponatremia: Seek and You Will Find
Nephron Physiol 118:66-71, Hoorn, E.J.,et al, 2011

Advanced Brain Imaging Studies Should Be Performed in Patients With Suspected Stroke Presenting Within 4.5 Hours of Symptom Onset
Stroke 42-2666-2667,2670, Parsons, M.W., 2011

Advanced Brain Imaging Studies Should Not Be Performed in Patients With Suspected Stroke Presenting Within 4.5 Hours of Symptom Onset
Stroke 42:2668-2669,2670, Lyden, P.D., 2011

Safety and Functional Outcome of Thrombolysis in Dissection-Related Ischemic Stroke A Meta-Analysis of Individual Patient Data
Stroke 42:2515-2520, Zinkstok, S.M.,et al, 2011

Effects of Extending the Time Window of Thrombolysis to 4.5 Hours Observations in the Swedish Stroke Register (Riks-Stroke)
Stroke 42:2492-2497, Asplund, K.,et al, 2011

An Acutely Confused Young Woman
Lancet 378-456, Casetta, I,.et al, 2011

"Bath Salts" Intoxication
NEJM 365:967-968, Ross, E.A.,et al, 2011

Immune Reconstitution Inflammatory Syndrome in Natalizumab-Associated PML
Neurol 77:1061-1067,1033, Tan, I.L.,et al, 2011

Clinical Reasoning: A 34-year-old man with recurrent limb weakness
Neurol 77:e68-e72, Karam, C.,et al, 2011

Intraventricular Fibrinolysis Versus External Ventricular Drainage Alone in Intraventricular Hemorrhage
Stroke 42:2776-2781, Gaberel, T.,et al, 2011

Autoimmune Limbic Encephalitis with GAD Antibodies
The Neurohospitalist 1:178-181, Finelli, P.F., 2011

Clinicopathologic Conference, Limbic Encephaitis with Antibodies to Leucine - Rich Glioma - inactivated 1 (LGI 1).
NEJM 365:1825-1833, Case 34-2011, 2011

Low-Dose Recombinant Tissue-Type Plasminogen Activator Enhances Clot Resolution in Brain Hemorrhage
Stroke 42:3009-3016,2999, Naff, N.,et al, 2011

The Cost-Effectiveness of Telestroke in the Treatment of Acute Ischemic Stroke
Neurol 77:1590-1598, Nelson, R.E.,et al, 2011

Intravenous Dihydroergotamine for Inpatient Management of Refractory Primary Headaches
Neurol 77:1827-1832, Nagy, A.J.,et al, 2011

Relationship Between Chronic Atrial Fibrillation and Worse Outcomes in Stroke Patients After Intravenous Thrombolysis
Arch Neurol 68:1454-1458, Seet, R.C.S.,et al, 2011

Thrombolytic Treatment of Patients with Acute Ischemic Stroke Related to Underlying Arterial Dissection in the United States
Arch Neurol 68:1536-1542, Qureshi, A.I.,et al, 2011

Intraventricular Hemorrhage
UpToDate, Sept, Cucchiara B.L. and Pacelli, J.P., 2011

Association Between Stroke Center Hospitalization for Acute Ischemic Stroke and Mortality
JAMA 305:373-380, Xian,Y.,et al, 2011



Showing articles 550 to 600 of 1768 << Previous Next >>